Japan Approves Biosimilar Teriparatide And Darbepoetin

 
• By Aidan Fry
  
Bone_Structure
Mochida says it has received Japan's first approval for a biosimilar version of the osteoporosis drug teriparatide • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products